Sensex Today Trades Higher | REC & Zee Entertainment Jump 6% | SBI, Hindalco Top Gainers

Wed, 24 Jan 10:30 am

   Previous Close   

   Pre-Open   

   Closing   

Asian stocks were off to a sluggish start on Wednesday.

The Nikkei index was trading 0.2% higher, while Hang Seng was trading 1.4% higher. Meanwhile Shanghai index is trading marginally higher.

The S&P 500 climbed to a record high close on Tuesday as investors digested a mixed bag of early quarterly results and awaited a slew of additional reports from Tesla and other companies later this week.

Here's a table showing how US stocks performed on Tuesday:

Stock/Index	LTP	Change ($)	Change (%)	Day High	Day Low	52-Week High	52-Week Low
Alphabet	148.68	0.97	0.66%	148.86	147.19	150.01	88.86
Apple	195.18	1.29	0.67%	195.75	193.83	199.62	138.81
Meta	385.2	3.42	0.90%	388.38	382.08	390.35	140.31
Tesla	209.14	0.34	0.16%	215.65	207.75	299.29	138.07
Netflix	492.19	6.48	1.33%	498.96	481.4	503.41	285.33
Amazon	156.02	1.24	0.80%	156.21	153.93	157.17	88.12
Microsoft	398.9	2.39	0.60%	399.38	393.93	400.62	230.9
Dow Jones	37905.45	-96.36	-0.25%	37980.73	37804.99	38109.2	31429.82
Nasdaq	17404.21	73.82	0.43%	17410.86	17286.02	17450.3	11550.07

Source: Equitymaster

At present, the BSE Sensex is up 200 points and NSE Nifty is trading 66 points higher.

Hindalco, SBI and Tata Steel are among the top gainers today.

Axis Bank, Asian Paints and Eicher Motors on the other hand are among the top losers today.

Broader markets are trading on mixed. The BSE Mid Cap is trading 0.6% higher and the BSE Small Cap index is trading 1% higher.

Sectoral indices are trading mixed, with socks in metal sector, telecom sector and energy sector witnessing most buying. Meanwhile, stocks in realty auto and banking sector witnessed selling pressure.

The rupee is trading at Rs 83.15 against the US dollar.

In commodity markets, gold prices are trading marginally higher at Rs 61,997 per 10 grams today.

Meanwhile, silver prices are trading marginally higher at Rs 71,000 per 1 kg.

Now track the biggest movers of the stock market using stocks to watch today section. This should help you keep updated with the latest developments...

Speaking of stock markets, India's three leading exchanges, BSE, MCX and IEX operate in different genres.

One is a stock exchange (operating in financial sector).

The second is a commodity exchange (operating in manufacturing sector).

The third is an energy exchange (operating in infrastructure sector).

All three exchanges are listed. Also, they are perceived by investors as the gateway to the long-term prosperity of the underlying sector they operate in.

Which one could be a future multibagger?

Tanushree Banerjee co-head of research at Equitymaster, answers these questions in below video.

Pidilite Industries Q3 Profit Jumps 66%

India's Pidilite Industries posted a nearly 68% jump in third-quarter profit on Tuesday, the adhesive maker's biggest year-over-year growth in nine quarters, driven by sustained demand and easing costs.

Consolidated net profit rose to Rs 5.1 billion (bn) (US$61 million) in the October-December period from Rs 3 bn a year earlier.

The rising construction and infrastructure activity in the country drove demand for construction chemicals, which benefited industrial adhesives and chemical manufacturers like Pidilite.

The company's revenue increased 4% to Rs 31.3 bn during the quarter.

Sales increased 5% in its consumer and bazaar business, which accounts for nearly 81% of the total revenue. The segment houses Fevicol and the company's waterproofing brand Dr Fixit.

A drop in the average price of vinyl acetate monomer, a crucial raw material for adhesives, helped pull down Pidilite's total costs by 4%.

The company's shares closed down 5.8% ahead of results. They rose 11.3% in the third quarter.

For more, check out The 5 Most Overvalued Stocks in India. Will these Stocks Crash in 2024?

Tata Elxsi Q3 Results

Tata Elxsi shares will be in focus after the design and technology services company reported a 3.2% on-quarter and a 6% on-year growth in net profit at Rs 2.1 billion (bn) for the December 2023 quarter.

Tata Elxsi reported a 3.7% on-quarter and 11.8% on-year growth in revenue at Rs 9.1 bn.

The company is a provider of design and technology services across industries, including automotive, broadcast, communications, healthcare and transportation.

For Q3FY24, the transportation segment grew 2.7% quarter-on-quarter (QoQ), aided by deal wins and ramp-up of Software Defined Vehicle engagements.

For the same period, the healthcare division grew 4.6% QoQ, driven by product engineering and regulatory services. The media and communications segment grew marginally by 0.6% QoQ.

Over the past month, shares of the company have lost 7.5% in trade. In comparison, the Nifty 50 index has slipped less than 1% in the same period.

As you're interested in Tata group stocks, check out the new section in our Stock Screener, where you can view the fundamentals of companies within a business group in one screen, including the Top Tata group stocks.

Lupin Receives USFDA Approval

Pharmaceutical giant Lupin announced today that it has secured tentative approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Rivaroxaban Tablets.

These tablets are a generic equivalent of Janssen Pharmaceuticals' Xarelto Tablets, a popular blood thinner used for various cardiovascular conditions.

The approved tablets come in four dosages - 2.5 mg, 10 mg, 15 mg, and 20 mg - and are indicated for a wide range of conditions, including reducing the risk of stroke and systemic embolism in nonvalvular atrial fibrillation, treating deep vein thrombosis (DVT) and pulmonary embolism (PE), reducing major cardiovascular events in patients with coronary artery disease (CAD), etc.

The approval allows Lupin to enter the lucrative market for anticoagulant medications, providing more alternatives to patients. The company will manufacture Rivaroxaban Tablets at its facility in Pithampur, India.

Xarelto, the reference-listed drug (RLD), had estimated annual sales of US$ 8,249 million in the US as of November 2023.

Lupin's portfolio includes branded and generic formulations, biotechnology products, and Active Pharmaceutical Ingredients (APIs). The company operates in over 100 markets globally, with a presence in the US, South Africa, Asia Pacific, Latin America, Europe, and the Middle East.

Lupin holds leadership positions in the cardiovascular, anti-diabetic, and respiratory segments and has a significant presence in the anti-infective, gastrointestinal (GI), central nervous system (CNS), and women's health areas. In the US, Lupin ranks as the third-largest pharmaceutical company by prescriptions.

Lupin boasts 15 manufacturing sites, 7 research centres, and a global team of more than 20,000 professionals.

To know what's moving the Indian stock markets today, check out the most recent share market updates here.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Top Gainers TodayTop Gainers over 1-WeekTop Gainers over 1-MonthTop Gainers over 1-YearTop Gainers over 3-YrsTop Gainers over 5-YrsTop Losers TodayTop Losers over 1-WeekTop Losers over 1-MonthTop Losers over 1-YearTop Losers over 3-YrsTop Losers over 5-YrsOnly BuyersOnly SellersMost Active StocksMost Popular Stocks52 Week High Stocks52 Week Low Stocks

INDICESBSE (Rs 0 to 1)BSE (Rs 1 to 2)BSE (Rs 2 to 4)BSE (Rs 4 to 10)BSE (Rs 10 to 20)BSE (Above Rs 20)BSE - AllBSE-30BSE-100BSE-200BSE-500BSE AutoBSE BankexBSE Capital GoodsBSE Consumer DurablesBSE FMCGBSE HealthcareBSE ITBSE MetalBSE Oil & GasBSE PSUBSE TeckBSE RealtyBSE PowerBSE A GroupBSE B GroupBSE Mid-CapBSE Small-CapBSE Basic MaterialsBSE Consumer DiscretionaryBSE IndustrialsBSE UtilitiesBSE Sensex 50BSE Sensex Next 50BSE Bharat 22BSE 150 MidCapBSE 250 SmallCapBSE 250 LargeMidCapBSE 400 MidSmallCapBSE AllCapBSE LargeCapBSE SmallCap SelectBSE 100 LargeCap TMCBSE InfraBSE ManufacturingBSE CPSEBSE Private BankBSE Diversified FinancialsBSE MomentumBSE Low VolatilityBSE QualityBSE Enhanced ValueBSE Divident StabilityS&P BSE IPOBSE SMEIPOBSE 100 ESGBSE CarbonexBSE GreenexNSE (Rs 0 to 10)NSE (Rs 10 to 20)NSE (Above Rs 20)NSE - AllNSE-50NSE ITNSE Nifty Midcap 50NSE JR. NiftyNSE Bank NiftyNIFTY Next 50NIFTY 100NIFTY 200NIFTY 500NIFTY MidCap 100NIFTY SmallCap 250NIFTY SmallCap 50NIFTY SmallCap 100NIFTY LargeMidCap 250NIFTY MidSmallCap 400NIFTY AutoNIFTY Consumer DurablesNIFTY FinanceNIFTY FMCGNIFTY MediaNIFTY MetalNIFTY PharmaNIFTY Private BankNIFTY PSU BankNIFTY RealtyNIFTY Oil & GasNIFTY SME EmergeNIFTY CommoditiesNIFTY CPSENIFTY EnergyNIFTY India ConsumptionNIFTY InfraNIFTY MNCNIFTY PSENIFTY Serv SectorNIFTY100 Liquid 15NIFTY Midcap Liquid 15NIFTY Midcap 150 Quality 50NIFTY50 Equal WeightNIFTY100 Equal WeightNIFTY100 Low Volatility 30NIFTY100 Alpha 30NIFTY Alpha 50NIFTY Dividend Opportunities 50NIFTY High Beta 50NIFTY Low Volatility 50NIFTY200 Quality 30NIFTY 500 Value 50NIFTY 100 Quality 30SECTORSAgricultureAirlinesAluminiumAsset Management CompaniesAutomobilesAuto AncillariesBanks (Private)Banks (PSU)BankingCementChemicalsDefenceDiagnosticsDronesEngineeringElectric VehicleElectric Vehicle BatteryEnergy SourcesESGEthanolFertilizersFintechFMCGFoodGreen HydrogenHotelsInfrastructureInsuranceInvestment and FinanceInvITIT (Large)IT (Others)LogisticsMediaMetalMiningIndia's Big Tech StocksIndian PharmaMNC PharmaPSUPaintPaperPlasticPowerRating AgenciesReal EstateREITsRenewable EnergyRetailingSemiconductorShippingSteelSugarSupply ChainTelecomTextilesTravel Support Services

10 results 25 results 50 results 100 results All results

Indian Share Market Update: Top Gainers and Losers